A Novel PD-L1-Containing MSLN Targeting Vaccine for Lung Cancer Immunotherapy.
Zeng W, Pan J, Fang Z, Jia J, Zhang R, He M, Zhong H, He J, Yang X, Shi Y, Zhong B, Zeng J, Fu B, Huang M, Liu H.
Zeng W, et al.
Front Immunol. 2022 Jun 20;13:925217. doi: 10.3389/fimmu.2022.925217. eCollection 2022.
Front Immunol. 2022.
PMID: 35795680
Free PMC article.